These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35149658)

  • 21. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
    Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
    JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncovering survivorship bias in longitudinal mental health surveys during the COVID-19 pandemic.
    Czeisler MÉ; Wiley JF; Czeisler CA; Rajaratnam SMW; Howard ME
    Epidemiol Psychiatr Sci; 2021 May; 30():e45. PubMed ID: 34036933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV: Survey Results From the MACS-WIHS Combined Cohort Study.
    D'Souza G; Tong W; Gustafson D; Alcaide ML; Lahiri CD; Sharma A; French AL; Palella FJ; Kempf MC; Mimiaga MJ; Ramirez C; Kassaye S; Rinaldo CR; Brown TT; Tien PC; Adimora AA
    J Acquir Immune Defic Syndr; 2022 Jan; 89(1):1-8. PubMed ID: 34878431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geographic Information System mapping as a tool to assess nonresponse bias in survey research.
    Hansen RA; Henley AC; Brouwer ES; Oraefo AN; Roth MT
    Res Social Adm Pharm; 2007 Sep; 3(3):249-64. PubMed ID: 17945157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating demographic differences in patients' decisions to consent to COVID-19 research.
    Robertson K; Reimold K; Moormann AM; Binder R; Matteson KA; Leftwich HK
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2148097. PubMed ID: 36597819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey nonresponse among informal caregivers: effects on the presence and magnitude of associations with caregiver burden and satisfaction.
    Oldenkamp M; Wittek RP; Hagedoorn M; Stolk RP; Smidt N
    BMC Public Health; 2016 Jun; 16():480. PubMed ID: 27278386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.
    Siegler AJ; Sullivan PS; Sanchez T; Lopman B; Fahimi M; Sailey C; Frankel M; Rothenberg R; Kelley CF; Bradley H
    Ann Epidemiol; 2020 Sep; 49():50-60. PubMed ID: 32791199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional study.
    Mendiboure V; Teiti I; Aubry M; Teissier A; Paoaafaite T; Vanhomwegen J; Manuguerra JC; Fontanet A; Cao-Lormeau VM; Madec Y
    BMC Public Health; 2024 Feb; 24(1):382. PubMed ID: 38317107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronavirus Disease 2019 (COVID-19) Perinatal Outcomes Across the Pandemic at an Academic Medical Center in New York City.
    Seaton CL; Cohen A; Henninger EM; Gendlina I; Hou W; Bernstein PS; Duong TQ
    Obstet Gynecol; 2023 Jan; 141(1):144-151. PubMed ID: 36302251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Two Different Recruitment Procedures (Random vs. Volunteer Selection) on the Results of Seroepidemiological Study (SARS-CoV-2).
    Gajda M; Kowalska M; Zejda JE
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of nonresponse bias in an internet survey of alcohol use.
    Kypri K; Stephenson S; Langley J
    Alcohol Clin Exp Res; 2004 Apr; 28(4):630-4. PubMed ID: 15100615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis.
    Jahan N; Brahma A; Kumar MS; Bagepally BS; Ponnaiah M; Bhatnagar T; Murhekar MV
    Int J Infect Dis; 2022 Mar; 116():59-67. PubMed ID: 34968773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population Behavior Changes Underlying Phasic Shifts of SARS-CoV-2 Exposure Settings Across 3 Omicron Epidemic Waves in Hong Kong: Prospective Cohort Study.
    Chan CP; Lee SS; Kwan TH; Wong SYS; Yeoh EK; Wong NS
    JMIR Public Health Surveill; 2024 Jun; 10():e51498. PubMed ID: 38896447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.